433331-38-5

Upstream product

• 433331-36-3 4-allyloxy-2'-(methoxymethyloxy)diphenylmethanol 
• 25244-30-8 4-(allyloxy)bromobenzene 
• 5533-04-0 2-(methoxymethoxy)benzaldehyde 
• 606-12-2 4-[(2-hydroxyphenyl)carbonyl]phenol 
• 106-95-6 allyl bromide 
• 114450-98-5 4-allyloxybromobenzene Grignard reagent 
• 433331-37-4 4-allyloxy-2'-(methoxymethyloxy)benzophenone 
• 144-55-8 sodium hydrogencarbonate 

Downstream Products

• 433331-39-6 2-(4-allyloxybenzyl)phenol 

Relevant academic research and scientific papers

Benzophenone type derivative photoinitiator and preparation method thereof

The invention belongs to the field of photosensitive high polymer materials. After a hydrogen abstraction type photoinitiator absorbs light energy, the photoinitiator produces a bimolecular action with an auxiliary initiator in an excited state to generat

GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND MEDICINAL USE THEREOF

The present invention provides glucopyranosyloxybenzylbenzene derivatives represented by the general formula: wherein P represents a hydrogen atom or a group forming a prodrug; R1 represents a hydrogen atom, an optionally substituted amino grou

GLUCOPYRANOSYLOXYBENZYL BENZENE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATES IN THE PRODUCTION THEREOF

The present invention relates to glucopyranosyloxybenzylbenzene derivatives represented by the general formula: wherein R1 represents a hydrogen atom, a hydroxy group, a substituted or unsubstituted amino group, a carbamoyl group, a substituted or unsubstituted(lower alkyl) group, a substituted or unsubstituted(lower alkoxy) group etc.; R2 represents a hydrogen atom or a lower alkyl group; and R3 represents a substituted or unsubstituted(lower alkyl) group, a substituted or unsubstituted(lower alkoxy) group, a substituted or unsubstituted (lower alkylthio) group etc., or pharmaceutically acceptable salts thereof, which have an inhibitory activity in human SGLT2 and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complication or obesity, pharmaceutical compositions comprising the same and intermediates thereof.